Nutcracker Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Nutcracker Therapeutics is a small to mid-sized biotechnology CRDMO based in Emeryville, California, focused on RNA. The company combines engineering with high-precision biosynthesis to enable RNA-based therapeutics. Its platform covers the design, delivery, and manufacturing of RNA molecules, with the aim of reducing costs and cycle times while maintaining high quality.

Its customers are RNA drug developers seeking CRDMO services, including support for small-scale mRNA applications. Operating in the biotechnology research industry, it positions itself as a provider of precision RNA biomanufacturing. In March 2025, Nutcracker Therapeutics announced leadership changes with Cynthia Collins appointed executive chair and interim CEO, following the retirement of Igor Khandros.

Sign up for free to view info

Company overview Employee directory